|
Miralles-López J.C., Alvarez-Gutiérrez F.J., Delgado-Romero J., Quirce S., Soto-Campos J.G., Andújar-Espinosa R., Cabrejos-Perotti S., Castilla-Martínez M., Flores-Martín I., Pajarón-Fernández M.J., Valverde-Molina J. Disease Modification in Asthma: Are We on the Right Way? A Multidisciplinary Expert Delphi Consensus (MODIASTHMA Consensus). Journal of Asthma and Allergy. 2024. 17:1163-1171. 10.2147/JAA.S488764
AÑO: 2024; IF: 3.0
|
|
Hu-Yang C., Perez-Fernandez V., Andreu Rodríguez A.L., Andújar Espinosa R., Valverde-Molina J. [Translated article] FEV1/FVC Cut-off Values for the Diagnosis of Airflow Obstruction in Pediatric Patients: The Pediatric Airflow Obstruction (PAO) Study. Archivos de Bronconeumologia. May 2022. 58:T442-T443. 10.1016/j.arbres.2021.03.028
AÑO: 2022; IF: 8.0
|
|
Miralles-Lopez JC, Cortes Collado JJ, Petryk Petryk Y, Bravo-Gutierrez FJ, Andujar-Espinosa R, Ramirez Hernandez M, Castilla-Martinez M, Diaz-Chantar C, Ibarra-Calabuig I, Valverde-Molina J, Perez-Fernandez V, Group RA. Real-life efficacy of Tezepelumab in patients with failure to other biologic drugs. Eur Ann Allergy Clin Immunol. 2025 Oct 10. doi: 10.23822/EurAnnACI.1764-1489.416. Online ahead of print. No abstract available. PubMed PMID: 41070810.
AÑO: 2025; IF: 2.3
|